Different Contribution of Apoptosis to the Antiproliferative Effects of L-Arginine, Enalapril and Losartan on Neointimal Growth Inhibition After Balloon Arterial Injury
It remains to be clarified how angiotensin-converting enzyme inhibitor-induced function (ie, increased NO related action or the inhibition of angiotensin II AT1 receptor dependent action) affects apoptosis of smooth muscle cells in the neointima following arterial injury. Saline (control), enalapril...
Gespeichert in:
Veröffentlicht in: | Circulation Journal 2002, Vol.66(10), pp.965-971 |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 971 |
---|---|
container_issue | 10 |
container_start_page | 965 |
container_title | Circulation Journal |
container_volume | 66 |
creator | Ohwada, Takayuki Ishibashi, Toshiyuki Yaoita, Hiroyuki Shindo, Joji Noji, Hideyoshi Ohkawara, Hiroyuki Sugimoto, Kouichi Sakamoto, Takayuki Maehara, Kazuhira Maruyama, Yukio |
description | It remains to be clarified how angiotensin-converting enzyme inhibitor-induced function (ie, increased NO related action or the inhibition of angiotensin II AT1 receptor dependent action) affects apoptosis of smooth muscle cells in the neointima following arterial injury. Saline (control), enalapril, L-arginine, combined enalapril and L-arginine, or losartan was administered for 14 days to Sprague-Dawley rats after balloon carotid injury and the ratio of intima to media areas (I/M), inducible NO synthase (iNOS) concentrations and %TUNEL were measured. I/M decreased similarly in the enalapril, L-arginine and losartan groups, and the combination of enalapril and L-arginine resulted in the largest I/M decrease. TUNEL positivity was increased compared with controls in the following order: losartan, L-arginine, enalapril and combination of enalapril and L-arginine. The intensity of immunostaining for iNOS was increased approximately 1.9-fold compared with the control in the combined enarapril and L-arginine group as well as in the enalapril group. These data suggest that the apoptosis in the neointima is different for L-arginine, losartan and enalapril under similar conditions and was higher under treatment with enalapril, not only via the action of NO or blocking of the AT1, but also by upregulation of iNOS. (Circ J 2002; 66: 965 - 971) |
doi_str_mv | 10.1253/circj.66.965 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_72184380</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>72184380</sourcerecordid><originalsourceid>FETCH-LOGICAL-c608t-64d2e6ffa1bf6943b14004b9855f9aecea53aaba0f703a05121931913b91f4d83</originalsourceid><addsrcrecordid>eNpFkU2P0zAQhiMEYpeFG2fkC5w2xY4dNz6GUpZKFVzgHE3c8daVaxfbAe0_4mfifohebI_8zDsfb1W9ZXTGmpZ_1Dbq3UzKmZLts-qWcTGvRdfQ56e3rFUn-E31KqUdpY2irXpZ3bCGd4wqcVv9_WyNwYg-k0XwOdpxyjZ4EgzpD-GQQ7KJ5EDyFknvsz3E4GxJgGx_I1mWXJ3TkV7XfXy03nq8J0sPDg7ROgJ-Q9YhQcxQND35hsEWlT048hDDn7wlK7-1oz3V7E3GSD6Bc-EYxRLZAq78bopPr6sXBlzCN5f7rvr5Zflj8bVef39YLfp1rSXtci3FpkFpDLDRSCX4yASlYlRd2xoFqBFaDjACNXPKgbasYYozxfiomBGbjt9VH866ZdJfE6Y87G3S6Bx4DFMa5g0rC-1oAe_PoI4hpYhmKBPvIT4NjA5HZ4aTM4OUQ3Gm4O8uutO4x80VvlhRgPcXAJIGZyJ4bdOVE6wMIVnhFmdulzI84n-g7Nhqh9eqpY3zWcpff7cQB_T8H1cVsrc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>72184380</pqid></control><display><type>article</type><title>Different Contribution of Apoptosis to the Antiproliferative Effects of L-Arginine, Enalapril and Losartan on Neointimal Growth Inhibition After Balloon Arterial Injury</title><source>J-STAGE Free</source><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Ohwada, Takayuki ; Ishibashi, Toshiyuki ; Yaoita, Hiroyuki ; Shindo, Joji ; Noji, Hideyoshi ; Ohkawara, Hiroyuki ; Sugimoto, Kouichi ; Sakamoto, Takayuki ; Maehara, Kazuhira ; Maruyama, Yukio</creator><creatorcontrib>Ohwada, Takayuki ; Ishibashi, Toshiyuki ; Yaoita, Hiroyuki ; Shindo, Joji ; Noji, Hideyoshi ; Ohkawara, Hiroyuki ; Sugimoto, Kouichi ; Sakamoto, Takayuki ; Maehara, Kazuhira ; Maruyama, Yukio</creatorcontrib><description>It remains to be clarified how angiotensin-converting enzyme inhibitor-induced function (ie, increased NO related action or the inhibition of angiotensin II AT1 receptor dependent action) affects apoptosis of smooth muscle cells in the neointima following arterial injury. Saline (control), enalapril, L-arginine, combined enalapril and L-arginine, or losartan was administered for 14 days to Sprague-Dawley rats after balloon carotid injury and the ratio of intima to media areas (I/M), inducible NO synthase (iNOS) concentrations and %TUNEL were measured. I/M decreased similarly in the enalapril, L-arginine and losartan groups, and the combination of enalapril and L-arginine resulted in the largest I/M decrease. TUNEL positivity was increased compared with controls in the following order: losartan, L-arginine, enalapril and combination of enalapril and L-arginine. The intensity of immunostaining for iNOS was increased approximately 1.9-fold compared with the control in the combined enarapril and L-arginine group as well as in the enalapril group. These data suggest that the apoptosis in the neointima is different for L-arginine, losartan and enalapril under similar conditions and was higher under treatment with enalapril, not only via the action of NO or blocking of the AT1, but also by upregulation of iNOS. (Circ J 2002; 66: 965 - 971)</description><identifier>ISSN: 1346-9843</identifier><identifier>EISSN: 1347-4820</identifier><identifier>DOI: 10.1253/circj.66.965</identifier><identifier>PMID: 12381094</identifier><language>eng</language><publisher>Kyoto: The Japanese Circulation Society</publisher><subject>ACE inhibitor ; Angiotensin-Converting Enzyme Inhibitors - pharmacology ; Animals ; Apoptosis ; Apoptosis - drug effects ; Arginine - pharmacology ; Atherosclerosis ; Biological and medical sciences ; Carotid Artery Injuries - drug therapy ; Carotid Artery Injuries - etiology ; Catheterization - adverse effects ; Cell Division - drug effects ; Diseases of the cardiovascular system ; Enalapril - pharmacology ; Graft Occlusion, Vascular - drug therapy ; Losartan - pharmacology ; Male ; Medical sciences ; Muscle, Smooth, Vascular - drug effects ; Muscle, Smooth, Vascular - enzymology ; Muscle, Smooth, Vascular - pathology ; Nitric oxide ; Nitric Oxide Synthase - biosynthesis ; Nitric Oxide Synthase - drug effects ; Nitric Oxide Synthase Type II ; Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects) ; Rats ; Rats, Sprague-Dawley ; Restenosis ; Up-Regulation - drug effects</subject><ispartof>Circulation Journal, 2002, Vol.66(10), pp.965-971</ispartof><rights>2002 THE JAPANESE CIRCULATION SOCIETY</rights><rights>2002 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c608t-64d2e6ffa1bf6943b14004b9855f9aecea53aaba0f703a05121931913b91f4d83</citedby><cites>FETCH-LOGICAL-c608t-64d2e6ffa1bf6943b14004b9855f9aecea53aaba0f703a05121931913b91f4d83</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,1877,4010,27900,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=14198561$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12381094$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ohwada, Takayuki</creatorcontrib><creatorcontrib>Ishibashi, Toshiyuki</creatorcontrib><creatorcontrib>Yaoita, Hiroyuki</creatorcontrib><creatorcontrib>Shindo, Joji</creatorcontrib><creatorcontrib>Noji, Hideyoshi</creatorcontrib><creatorcontrib>Ohkawara, Hiroyuki</creatorcontrib><creatorcontrib>Sugimoto, Kouichi</creatorcontrib><creatorcontrib>Sakamoto, Takayuki</creatorcontrib><creatorcontrib>Maehara, Kazuhira</creatorcontrib><creatorcontrib>Maruyama, Yukio</creatorcontrib><title>Different Contribution of Apoptosis to the Antiproliferative Effects of L-Arginine, Enalapril and Losartan on Neointimal Growth Inhibition After Balloon Arterial Injury</title><title>Circulation Journal</title><addtitle>Circ J</addtitle><description>It remains to be clarified how angiotensin-converting enzyme inhibitor-induced function (ie, increased NO related action or the inhibition of angiotensin II AT1 receptor dependent action) affects apoptosis of smooth muscle cells in the neointima following arterial injury. Saline (control), enalapril, L-arginine, combined enalapril and L-arginine, or losartan was administered for 14 days to Sprague-Dawley rats after balloon carotid injury and the ratio of intima to media areas (I/M), inducible NO synthase (iNOS) concentrations and %TUNEL were measured. I/M decreased similarly in the enalapril, L-arginine and losartan groups, and the combination of enalapril and L-arginine resulted in the largest I/M decrease. TUNEL positivity was increased compared with controls in the following order: losartan, L-arginine, enalapril and combination of enalapril and L-arginine. The intensity of immunostaining for iNOS was increased approximately 1.9-fold compared with the control in the combined enarapril and L-arginine group as well as in the enalapril group. These data suggest that the apoptosis in the neointima is different for L-arginine, losartan and enalapril under similar conditions and was higher under treatment with enalapril, not only via the action of NO or blocking of the AT1, but also by upregulation of iNOS. (Circ J 2002; 66: 965 - 971)</description><subject>ACE inhibitor</subject><subject>Angiotensin-Converting Enzyme Inhibitors - pharmacology</subject><subject>Animals</subject><subject>Apoptosis</subject><subject>Apoptosis - drug effects</subject><subject>Arginine - pharmacology</subject><subject>Atherosclerosis</subject><subject>Biological and medical sciences</subject><subject>Carotid Artery Injuries - drug therapy</subject><subject>Carotid Artery Injuries - etiology</subject><subject>Catheterization - adverse effects</subject><subject>Cell Division - drug effects</subject><subject>Diseases of the cardiovascular system</subject><subject>Enalapril - pharmacology</subject><subject>Graft Occlusion, Vascular - drug therapy</subject><subject>Losartan - pharmacology</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Muscle, Smooth, Vascular - drug effects</subject><subject>Muscle, Smooth, Vascular - enzymology</subject><subject>Muscle, Smooth, Vascular - pathology</subject><subject>Nitric oxide</subject><subject>Nitric Oxide Synthase - biosynthesis</subject><subject>Nitric Oxide Synthase - drug effects</subject><subject>Nitric Oxide Synthase Type II</subject><subject>Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects)</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Restenosis</subject><subject>Up-Regulation - drug effects</subject><issn>1346-9843</issn><issn>1347-4820</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkU2P0zAQhiMEYpeFG2fkC5w2xY4dNz6GUpZKFVzgHE3c8daVaxfbAe0_4mfifohebI_8zDsfb1W9ZXTGmpZ_1Dbq3UzKmZLts-qWcTGvRdfQ56e3rFUn-E31KqUdpY2irXpZ3bCGd4wqcVv9_WyNwYg-k0XwOdpxyjZ4EgzpD-GQQ7KJ5EDyFknvsz3E4GxJgGx_I1mWXJ3TkV7XfXy03nq8J0sPDg7ROgJ-Q9YhQcxQND35hsEWlT048hDDn7wlK7-1oz3V7E3GSD6Bc-EYxRLZAq78bopPr6sXBlzCN5f7rvr5Zflj8bVef39YLfp1rSXtci3FpkFpDLDRSCX4yASlYlRd2xoFqBFaDjACNXPKgbasYYozxfiomBGbjt9VH866ZdJfE6Y87G3S6Bx4DFMa5g0rC-1oAe_PoI4hpYhmKBPvIT4NjA5HZ4aTM4OUQ3Gm4O8uutO4x80VvlhRgPcXAJIGZyJ4bdOVE6wMIVnhFmdulzI84n-g7Nhqh9eqpY3zWcpff7cQB_T8H1cVsrc</recordid><startdate>2002</startdate><enddate>2002</enddate><creator>Ohwada, Takayuki</creator><creator>Ishibashi, Toshiyuki</creator><creator>Yaoita, Hiroyuki</creator><creator>Shindo, Joji</creator><creator>Noji, Hideyoshi</creator><creator>Ohkawara, Hiroyuki</creator><creator>Sugimoto, Kouichi</creator><creator>Sakamoto, Takayuki</creator><creator>Maehara, Kazuhira</creator><creator>Maruyama, Yukio</creator><general>The Japanese Circulation Society</general><general>Japanese Circulation Society</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>2002</creationdate><title>Different Contribution of Apoptosis to the Antiproliferative Effects of L-Arginine, Enalapril and Losartan on Neointimal Growth Inhibition After Balloon Arterial Injury</title><author>Ohwada, Takayuki ; Ishibashi, Toshiyuki ; Yaoita, Hiroyuki ; Shindo, Joji ; Noji, Hideyoshi ; Ohkawara, Hiroyuki ; Sugimoto, Kouichi ; Sakamoto, Takayuki ; Maehara, Kazuhira ; Maruyama, Yukio</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c608t-64d2e6ffa1bf6943b14004b9855f9aecea53aaba0f703a05121931913b91f4d83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>ACE inhibitor</topic><topic>Angiotensin-Converting Enzyme Inhibitors - pharmacology</topic><topic>Animals</topic><topic>Apoptosis</topic><topic>Apoptosis - drug effects</topic><topic>Arginine - pharmacology</topic><topic>Atherosclerosis</topic><topic>Biological and medical sciences</topic><topic>Carotid Artery Injuries - drug therapy</topic><topic>Carotid Artery Injuries - etiology</topic><topic>Catheterization - adverse effects</topic><topic>Cell Division - drug effects</topic><topic>Diseases of the cardiovascular system</topic><topic>Enalapril - pharmacology</topic><topic>Graft Occlusion, Vascular - drug therapy</topic><topic>Losartan - pharmacology</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Muscle, Smooth, Vascular - drug effects</topic><topic>Muscle, Smooth, Vascular - enzymology</topic><topic>Muscle, Smooth, Vascular - pathology</topic><topic>Nitric oxide</topic><topic>Nitric Oxide Synthase - biosynthesis</topic><topic>Nitric Oxide Synthase - drug effects</topic><topic>Nitric Oxide Synthase Type II</topic><topic>Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects)</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Restenosis</topic><topic>Up-Regulation - drug effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ohwada, Takayuki</creatorcontrib><creatorcontrib>Ishibashi, Toshiyuki</creatorcontrib><creatorcontrib>Yaoita, Hiroyuki</creatorcontrib><creatorcontrib>Shindo, Joji</creatorcontrib><creatorcontrib>Noji, Hideyoshi</creatorcontrib><creatorcontrib>Ohkawara, Hiroyuki</creatorcontrib><creatorcontrib>Sugimoto, Kouichi</creatorcontrib><creatorcontrib>Sakamoto, Takayuki</creatorcontrib><creatorcontrib>Maehara, Kazuhira</creatorcontrib><creatorcontrib>Maruyama, Yukio</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Circulation Journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ohwada, Takayuki</au><au>Ishibashi, Toshiyuki</au><au>Yaoita, Hiroyuki</au><au>Shindo, Joji</au><au>Noji, Hideyoshi</au><au>Ohkawara, Hiroyuki</au><au>Sugimoto, Kouichi</au><au>Sakamoto, Takayuki</au><au>Maehara, Kazuhira</au><au>Maruyama, Yukio</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Different Contribution of Apoptosis to the Antiproliferative Effects of L-Arginine, Enalapril and Losartan on Neointimal Growth Inhibition After Balloon Arterial Injury</atitle><jtitle>Circulation Journal</jtitle><addtitle>Circ J</addtitle><date>2002</date><risdate>2002</risdate><volume>66</volume><issue>10</issue><spage>965</spage><epage>971</epage><pages>965-971</pages><issn>1346-9843</issn><eissn>1347-4820</eissn><abstract>It remains to be clarified how angiotensin-converting enzyme inhibitor-induced function (ie, increased NO related action or the inhibition of angiotensin II AT1 receptor dependent action) affects apoptosis of smooth muscle cells in the neointima following arterial injury. Saline (control), enalapril, L-arginine, combined enalapril and L-arginine, or losartan was administered for 14 days to Sprague-Dawley rats after balloon carotid injury and the ratio of intima to media areas (I/M), inducible NO synthase (iNOS) concentrations and %TUNEL were measured. I/M decreased similarly in the enalapril, L-arginine and losartan groups, and the combination of enalapril and L-arginine resulted in the largest I/M decrease. TUNEL positivity was increased compared with controls in the following order: losartan, L-arginine, enalapril and combination of enalapril and L-arginine. The intensity of immunostaining for iNOS was increased approximately 1.9-fold compared with the control in the combined enarapril and L-arginine group as well as in the enalapril group. These data suggest that the apoptosis in the neointima is different for L-arginine, losartan and enalapril under similar conditions and was higher under treatment with enalapril, not only via the action of NO or blocking of the AT1, but also by upregulation of iNOS. (Circ J 2002; 66: 965 - 971)</abstract><cop>Kyoto</cop><pub>The Japanese Circulation Society</pub><pmid>12381094</pmid><doi>10.1253/circj.66.965</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1346-9843 |
ispartof | Circulation Journal, 2002, Vol.66(10), pp.965-971 |
issn | 1346-9843 1347-4820 |
language | eng |
recordid | cdi_proquest_miscellaneous_72184380 |
source | J-STAGE Free; MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals |
subjects | ACE inhibitor Angiotensin-Converting Enzyme Inhibitors - pharmacology Animals Apoptosis Apoptosis - drug effects Arginine - pharmacology Atherosclerosis Biological and medical sciences Carotid Artery Injuries - drug therapy Carotid Artery Injuries - etiology Catheterization - adverse effects Cell Division - drug effects Diseases of the cardiovascular system Enalapril - pharmacology Graft Occlusion, Vascular - drug therapy Losartan - pharmacology Male Medical sciences Muscle, Smooth, Vascular - drug effects Muscle, Smooth, Vascular - enzymology Muscle, Smooth, Vascular - pathology Nitric oxide Nitric Oxide Synthase - biosynthesis Nitric Oxide Synthase - drug effects Nitric Oxide Synthase Type II Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects) Rats Rats, Sprague-Dawley Restenosis Up-Regulation - drug effects |
title | Different Contribution of Apoptosis to the Antiproliferative Effects of L-Arginine, Enalapril and Losartan on Neointimal Growth Inhibition After Balloon Arterial Injury |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-19T00%3A53%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Different%20Contribution%20of%20Apoptosis%20to%20the%20Antiproliferative%20Effects%20of%20L-Arginine,%20Enalapril%20and%20Losartan%20on%20Neointimal%20Growth%20Inhibition%20After%20Balloon%20Arterial%20Injury&rft.jtitle=Circulation%20Journal&rft.au=Ohwada,%20Takayuki&rft.date=2002&rft.volume=66&rft.issue=10&rft.spage=965&rft.epage=971&rft.pages=965-971&rft.issn=1346-9843&rft.eissn=1347-4820&rft_id=info:doi/10.1253/circj.66.965&rft_dat=%3Cproquest_cross%3E72184380%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=72184380&rft_id=info:pmid/12381094&rfr_iscdi=true |